Focused Alpha’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Focused Alpha's GSK Position: Q3 2026 in Review
Focused Alpha increased its GSK (GSK) stake by 3.7% in Q3 2026, buying an estimated $12.4K and bringing the position to 6,764 shares worth $326K. The position accounts for 0.08% of the portfolio, ranked #209.
Focused Alpha first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $342K in Q2 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Focused Alpha held 6,764 shares of GSK worth $326K as of Q3 2026.
- Focused Alpha bought 242 GSK shares in Q3 2026, an estimated $12.4K.
- GSK made up 0.08% of Focused Alpha's portfolio in Q3 2026, its #209 holding.
- Focused Alpha first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
- Focused Alpha's GSK position peaked at $342K in Q2 2026.
- 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.